Cargando…

The Role of the L-Type Ca(2+) Channel in Altered Metabolic Activity in a Murine Model of Hypertrophic Cardiomyopathy

Heterozygous mice (αMHC(403/+)) expressing the human disease-causing mutation Arg403Gln exhibit cardinal features of hypertrophic cardiomyopathy (HCM) including hypertrophy, myocyte disarray, and increased myocardial fibrosis. Treatment of αMHC(403/+)mice with the L-type calcium channel (I(Ca-L)) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viola, Helena M., Johnstone, Victoria P.A., Cserne Szappanos, Henrietta, Richman, Tara R., Tsoutsman, Tatiana, Filipovska, Aleksandra, Semsarian, Christopher, Seidman, Jonathan G., Seidman, Christine E., Hool, Livia C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	PRE-CLINICAL RESEARCH
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113168/ https://www.ncbi.nlm.nih.gov/pubmed/30167506 http://dx.doi.org/10.1016/j.jacbts.2015.12.001

Ejemplares similares

Characterization and validation of a preventative therapy for hypertrophic cardiomyopathy in a murine model of the disease
por: Viola, Helena M., et al.
Publicado: (2020)

Preventative therapeutic approaches for hypertrophic cardiomyopathy
por: Solomon, Tanya, et al.
Publicado: (2020)

Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy
por: Cserne Szappanos, Henrietta, et al.
Publicado: (2023)

A maladaptive feedback mechanism between the extracellular matrix and cytoskeleton contributes to hypertrophic cardiomyopathy pathophysiology
por: Viola, Helena M., et al.
Publicado: (2023)

Evidence for redox sensing by a human cardiac calcium channel
por: Muralidharan, Padmapriya, et al.
Publicado: (2016)

Global MicroRNA Profiling of the Mouse Ventricles during Development of Severe Hypertrophic Cardiomyopathy and Heart Failure
por: Bagnall, Richard D., et al.
Publicado: (2012)

Identification of a novel cAMP dependent protein kinase A phosphorylation site on the human cardiac calcium channel
por: Cserne Szappanos, Henrietta, et al.
Publicado: (2017)

Author Correction: Identification of a novel cAMP dependent protein kinase A phosphorylation site on the human cardiac calcium channel
por: Szappanos, Henrietta Cserne, et al.
Publicado: (2018)

Mitochondrial mistranslation modulated by metabolic stress causes cardiovascular disease and reduced lifespan
por: Richman, Tara R., et al.
Publicado: (2021)

Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics
por: Teekakirikul, Polakit, et al.
Publicado: (2012)

Neuronal nitric oxide synthase regulation of calcium cycling in ventricular cardiomyocytes is independent of Ca(v)1.2 channel modulation under basal conditions
por: Ebner, Janine, et al.
Publicado: (2019)

A Morpholino Oligomer Therapy Regime That Restores Mitochondrial Function and Prevents mdx Cardiomyopathy
por: Viola, Helena M., et al.
Publicado: (2018)

Dystrophic Cardiomyopathy—Potential Role of Calcium in Pathogenesis, Treatment and Novel Therapies
por: Johnstone, Victoria P. A., et al.
Publicado: (2017)

Electrophysiological and Structural Remodeling of the Atria in a Mouse Model of Troponin-I Mutation Linked Hypertrophic Cardiomyopathy: Implications for Atrial Fibrillation
por: Lim, Wei-Wen, et al.
Publicado: (2021)

Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
por: Alamo, Lorenzo, et al.
Publicado: (2017)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
por: Margara, Francesca, et al.
Publicado: (2022)

Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
por: Fear, Vanessa S., et al.
Publicado: (2023)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)

Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
por: Reichart, Daniel, et al.
Publicado: (2023)

Glutathionylation of the L-type Ca(2+) Channel in Oxidative Stress-Induced Pathology of the Heart
por: Johnstone, Victoria P. A., et al.
Publicado: (2014)

Mutation in MRPS34 Compromises Protein Synthesis and Causes Mitochondrial Dysfunction
por: Richman, Tara R., et al.
Publicado: (2015)

Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy
por: Fahed, Akl C., et al.
Publicado: (2020)

Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered Mechanisms in Mitochondrial Dynamics and Excitation–Contraction Coupling
por: Moore, Jarrod, et al.
Publicado: (2023)

Adult-onset obesity is triggered by impaired mitochondrial gene expression
por: Perks, Kara L., et al.
Publicado: (2017)

Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers
por: Sweeting, Joanna, et al.
Publicado: (2016)

Getting inside the engine - myosin modulation in hypertrophic cardiomyopathy and systolic heart failure
por: Daniels, Matthew J, et al.
Publicado: (2021)

High Time Resolution Analysis of Voltage-Dependent and Voltage-Independent Calcium Sparks in Frog Skeletal Muscle Fibers
por: Cserne Szappanos, Henrietta, et al.
Publicado: (2020)

Development of a communication aid for explaining hypertrophic cardiomyopathy genetic test results
por: Smagarinsky, Yana, et al.
Publicado: (2017)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2016)

Loss of the RNA-binding protein TACO1 causes late-onset mitochondrial dysfunction in mice
por: Richman, Tara R., et al.
Publicado: (2016)

Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model
por: Axelsson Raja, Anna, et al.
Publicado: (2022)

Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies
por: Fish, Maryam, et al.
Publicado: (2016)

Presence Of Left Ventricular Non Compaction In Hypertrophic Cardiomyopathy Is Associated With Arrhythmia
por: Gnanappa, Ganesh Kumar, et al.
Publicado: (2016)

Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
por: Toepfer, Christopher N., et al.
Publicado: (2020)

Corrigendum: Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies
por: Fish, Maryam, et al.
Publicado: (2016)

Ventricular fibrillation and sudden cardiac arrest in apical hypertrophic cardiomyopathy: Two case reports
por: Park, Yae Min, et al.
Publicado: (2021)

Mitochondrial Energetics and Ca(2+)-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy
por: Lombardi, Maria, et al.
Publicado: (2020)

A Murine Hypertrophic Cardiomyopathy Model: The DBA/2J Strain
por: Zhao, Wenyuan, et al.
Publicado: (2015)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ks7i3ck99roohmssvrvj8i9djt